| Primary |
| Drug Use For Unknown Indication |
36.2% |
| Hiv Infection |
20.3% |
| Cytomegalovirus Infection |
11.4% |
| Immunosuppression |
6.5% |
| Renal Transplant |
3.2% |
| Encephalitis Cytomegalovirus |
2.5% |
| Mycobacterium Avium Complex Infection |
2.2% |
| Prophylaxis |
2.2% |
| Hypertension |
1.7% |
| Cytomegalovirus Chorioretinitis |
1.5% |
| Insomnia |
1.5% |
| Transplant |
1.5% |
| Cytomegalovirus Enterocolitis |
1.2% |
| Non-hodgkin's Lymphoma |
1.2% |
| Pneumonia Cytomegaloviral |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Transplant Rejection |
1.2% |
| Allergenic Desensitisation Procedure |
1.0% |
| Infection |
1.0% |
| Infection Prophylaxis |
1.0% |
|
| Death |
20.2% |
| Urogenital Disorder |
7.9% |
| Pneumonia |
7.0% |
| Pyrexia |
6.1% |
| Staphylococcal Sepsis |
5.3% |
| Cardiac Arrest |
4.4% |
| Hyponatraemia |
4.4% |
| Neutropenia |
4.4% |
| Urinary Tract Infection |
4.4% |
| Urosepsis |
4.4% |
| Meningitis Cryptococcal |
3.5% |
| Pancytopenia |
3.5% |
| Sepsis |
3.5% |
| Septic Shock |
3.5% |
| Transplant Rejection |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Cytomegalovirus Syndrome |
2.6% |
| Drug Ineffective |
2.6% |
| Hypoxia |
2.6% |
| Platelet Count Decreased |
2.6% |
|
| Secondary |
| Hiv Infection |
20.9% |
| Drug Use For Unknown Indication |
20.8% |
| Cytomegalovirus Infection |
5.8% |
| Antifungal Prophylaxis |
5.5% |
| Renal Transplant |
5.1% |
| Gastric Ulcer |
4.2% |
| Oesophageal Ulcer |
4.0% |
| Cytomegalovirus Chorioretinitis |
3.9% |
| Encephalitis Cytomegalovirus |
3.8% |
| Acquired Immunodeficiency Syndrome |
3.5% |
| Immunosuppression |
3.5% |
| Prophylaxis Against Transplant Rejection |
2.8% |
| Opportunistic Infection Prophylaxis |
2.7% |
| Antiviral Prophylaxis |
2.2% |
| Infection Prophylaxis |
2.2% |
| Drug Exposure During Pregnancy |
2.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Prophylaxis |
1.8% |
| Retroviral Infection |
1.7% |
| Insomnia |
1.6% |
|
| Pancytopenia |
12.8% |
| White Blood Cell Count Decreased |
11.9% |
| Umbilical Cord Abnormality |
7.3% |
| Urosepsis |
5.9% |
| Pneumocystis Jiroveci Pneumonia |
5.5% |
| Shock |
5.5% |
| Transplant Rejection |
5.5% |
| Hyponatraemia |
5.0% |
| Pyrexia |
4.6% |
| Renal Failure |
4.6% |
| Staphylococcal Sepsis |
4.6% |
| Neutropenia |
3.7% |
| Urinary Tract Infection |
3.7% |
| Renal Impairment |
3.2% |
| Septic Shock |
3.2% |
| Death |
2.7% |
| Rash |
2.7% |
| Renal Tubular Necrosis |
2.7% |
| Streptococcal Infection |
2.7% |
| Sepsis |
2.3% |
|
| Concomitant |
| Hiv Infection |
19.5% |
| Drug Use For Unknown Indication |
13.7% |
| Renal Transplant |
8.1% |
| Prophylaxis Against Transplant Rejection |
6.5% |
| Prophylaxis |
6.4% |
| Immunosuppression |
6.4% |
| Antifungal Prophylaxis |
5.6% |
| Infection Prophylaxis |
4.7% |
| Product Used For Unknown Indication |
4.6% |
| Tuberculosis |
3.8% |
| Antiviral Prophylaxis |
3.5% |
| Cytomegalovirus Chorioretinitis |
2.4% |
| Immunosuppressant Drug Therapy |
2.1% |
| Cytomegalovirus Infection |
2.1% |
| Hypertension |
2.0% |
| Liver Transplant |
1.9% |
| Premedication |
1.8% |
| Insomnia |
1.7% |
| Heart Transplant |
1.6% |
| Acquired Immunodeficiency Syndrome |
1.6% |
|
| White Blood Cell Count Decreased |
12.5% |
| Vomiting |
10.8% |
| Transplant Rejection |
9.1% |
| Pyrexia |
8.4% |
| Arrhythmia |
5.2% |
| Thrombocytopenia |
5.2% |
| Sepsis |
4.9% |
| Immune Reconstitution Syndrome |
4.5% |
| Renal Impairment |
4.2% |
| Hepatic Function Abnormal |
3.8% |
| Off Label Use |
3.8% |
| Respiratory Failure |
3.5% |
| Stomach Mass |
3.5% |
| Urinary Tract Infection |
3.5% |
| Neutropenia |
3.1% |
| Weight Increased |
3.1% |
| Renal Failure |
2.8% |
| Renal Failure Acute |
2.8% |
| Weight Decreased |
2.8% |
| Cytomegalovirus Infection |
2.4% |
|
| Interacting |
| Acquired Immunodeficiency Syndrome |
15.5% |
| Cytomegalovirus Chorioretinitis |
12.1% |
| Antiretroviral Therapy |
10.3% |
| Hiv Infection |
10.3% |
| Lung Transplant |
8.6% |
| Antifungal Prophylaxis |
5.2% |
| Anxiety |
5.2% |
| Nausea |
5.2% |
| Neutropenia |
5.2% |
| Opportunistic Infection Prophylaxis |
5.2% |
| Transplant |
5.2% |
| Drug Use For Unknown Indication |
3.4% |
| Prophylaxis |
3.4% |
| Cytomegalovirus Enteritis |
1.7% |
| Cytomegalovirus Infection |
1.7% |
| Gastric Disorder |
1.7% |
|
| Renal Tubular Necrosis |
42.9% |
| Lymphopenia |
14.3% |
| Nausea |
14.3% |
| Pancytopenia |
14.3% |
| Renal Failure |
14.3% |
|
